Article
Potential role of Hedgehog signaling pathway and myofibroblastic differentiation in central giant cell granuloma-A preliminary study
Registro en:
MUNIZ, Vinicius Rio Verde Melo et al. Potential role of Hedgehog signaling pathway and myofibroblastic differentiation in central giant cell granuloma-A preliminary study. Journal of Oral Pathology and Medicine, v. 48, p. 855–860, 2019.
0904-2512
10.1111/jop.12949
Autor
Muniz, Vinicius Rio Verde Melo
Nunes, Fábio Daumas
Xavier, Flávia Caló de Aquino
Cangussu, Maria Cristina Teixeira
Freitas, Rosean ade Almeida
Cury, Patrícia Ramos
Gurgel, Clarissa Araújo
Santos, Jean Nunes dos
Resumen
Gurgel, Clarissa Araújo. Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento. Conselho Nacional de Desenvolvimento
Científico e Tecnológico” (CNPq);
Coordenação de Aperfeiçoamento de Ensino
Superior (CAPES). This study investigated components of the Hedgehog (HH) signaling pathway (SHH, GLI1), cyclin D1, and smooth muscle actin (SMA) in central giant cell granulomas (CGCG). The relationship between these proteins and myofibroblasts was also studied. Material and methods: Twelve cases of non‐aggressive CGCG and 11 cases of aggressive
CGCG were studied using immunohistochemistry for SHH, GLI1, Cyclin D1,
and SMA.
Results: Associations between all proteins in non‐aggressive and aggressive CGCG were
not significant (P > .05). All cases of CGCG showed significantly higher expression of SMA
compared with the other proteins (P < .01). A positive correlation (P = .04) was only observed
between SHH and GLI1 for all cases of CGCG. Furthermore, a positive correlation
between SHH and GLI1 in non‐aggressive CGCG (P = .04) and between GLI1 and cyclin
D1 in aggressive CGCG (P = .03) were observed. There was also a negative correlation
between the expression of SHH and SMA in non‐aggressive CGCG (P = .031).
Conclusions: This study provided insights into the activation of the HH signaling
pathway in CGCG. In addition, the activation of this pathway (SHH and GLI1)
might play some role in the differentiation of stromal myofibroblasts, although these
markers including Cyclin D1 and SMA do not indicate aggressiveness of the CGCG.
Furthermore, this myofibroblastic differentiation process would occur at the expense
of maturation of these lesions. 2020-01-06